Hypogammaglobulinemia during antipsychotic therapy

Psychiatry and Clinical Neurosciences

Volumn 52, Issue 1, 1998, Pages 115-117

  Ade, Shuzo ^a,b   Suzuki, Toshihito ^a   Hori, Takafumi ^a   Baba, Atsuomi ^a,b   Shiraishi, Hiroyasu ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Mitsukaido Kosei Hospital   (Japan)

Author keywords

Antipsychotics; Chlorpromazine; Hypogammaglobulinemia

Indexed keywords

CHLORPROMAZINE; HALOPERIDOL; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LEVOMEPROMAZINE; NEUROLEPTIC AGENT; TIMIPERONE;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOGAMMAGLOBULINEMIA; IMMUNOGLOBULIN BLOOD LEVEL;

EID: 13144259712     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.1998.tb00983.x     Document Type: Article

References (12)

1. De Gast GC, The TH, Viersma JW, Marrink J, Arisaz LA. Reversible hypogammaglobulinemia after diphenylhydantoin and hydroxyzine therapy. Neth. J. Med. 1972; 17: 261-269.
2. Dosch HM, Janson J, Gelfand EW. Transient antibody deficiency and abnormal T suppressor cells induced by phenytoin. N. Eng. J. Med. 1972; 306: 406-409.
3. Garcia Rodriguez MC, de la Concha EG, Fontán G et al. Transient hypogammaglobulinemia in the adult: Functional assessment of T and B lymphocytes. J. Clin. Lab. Immunol. 1983; 11: 55-58.
4. Joubert PH, Aucamp AK, Potgieter GM, Verster F. Epilepsy and IgA deficiency: The effect of sodium valproate. S. Afr. Med. J. 1977; 52: 642-644.
5. Casano RT, de Oliveira RM, Nixon RA. Neuroleptic-associated auto-antibodies. A prevalence study. Biol. Psychiatry 1990; 27: 863-870.
6. Zucker S, Zarrabi HM, Sacubach WH et al. Chlorpromazine-induced immunopathy: Progressive increase in serum IgM. Medicine 1990; 69: 92-100.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. APA Washington, 1994.
8. Staverova GY, Menelaus NM, Anestis KM et al. Factor related to the presence of auto-antibodies in patients with chronic mental disorders. Biol. Psychiatry 1990; 27: 747-756.
9. Zarrabi MH, Zucker S, Miller H et al. Immunologic and coagulation disorder in chlorpromazine-treated patients. Ann. Intern. Med. 1979; 91: 194-198.
10. Furutsuka D, Nakanishi S, Yamagami S, Kawakita Y. A case of hypoimmunoglobulinemia induced by neuroleptics (chlorpromazine). Jpn. J. Psychiat. Treat. 1994; 9: 341-344 (in Japanese).
11. Barbu V, Maziere JC, Maindraut F et al. Effect of AY 9944 and chlorpromazine on concanavalin A-induced stimulation of human lymphocytes. Biochem. Pharmacol. 1987; 36; 353-356.
12. Martinez F, Coleman JW. The effects of selected drugs, including chlorpromazine and non-steroidal anti-inflammatory agents, on polyclonal IgG synthesis and interleukin 1 production by human peripheral blood mononuclear cells in vitro. Clin. Exp. Immunol. 1989; 76: 252-257.